CSIMarket
 
Mckesson Corporation  (NYSE: MCK)
 
Price: $885.3200 $-8.07 -0.903%
Day's High: $892.7849731445312 Week Perf: -2.18 %
Day's Low: $ 876.48 30 Day Perf: 3.4 %
Volume (M): 1,375,393 52 Wk High: $ 999.00
Volume (M$): $ 0 52 Wk Avg: $825.78
Open: $882.83 52 Wk Low: $682.35



 Market Capitalization (Millions $) 109,868
 Shares Outstanding (Millions) 124
 Employees 51,000
 Revenues (TTM) (Millions $) 403,430
 Net Income (TTM) (Millions $) 5,099
 Cash Flow (TTM) (Millions $) -1,888
 Capital Exp. (TTM) (Millions $) 745

Business Description


McKesson Corporation, is a Fortune 16 corporation providing supply, information and care management products and services designed to reduce costs and improve quality across the healthcare industry.

We conduct our business through three segments. Through our Pharmaceutical Solutions segment, we are a leading distributor of ethical and proprietary drugs, and health and beauty care products throughout North America. This segment also manufactures and sells automated pharmaceutical dispensing systems for hospitals and retail pharmacies, medical management and specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers, patient and payor services, consulting and outsourcing services to pharmacies and distribution of first-aid products in the United States. Our Medical-Surgical Solutions segment distributes medical-surgical supplies and equipment, and provides logistics and related services within the United States. Our Information Solutions segment delivers enterprise-wide patient care, clinical, financial, supply chain, managed care and strategic management software solutions, as well as outsourcing and other services, to healthcare organizations throughout North America, the United Kingdom and other European countries. The Company's strategy is to create strong, value-based relationships with customers, enabling us to sell additional products and services to these customers over time.

The U.S. Pharmaceutical Distribution business operates and serves over 30,000 locations through a network of 28 distribution centers, as well as a master distribution center and a repackaging facility, serving all 50 states. We invest in technology and other systems at all of our distribution centers to enhance safety, reliability and the best product availability for our customers. For example, in all of our distribution centers we use Acumax' Plus, a Smithsonian award-winning technology, which integrates and tracks all internal functions, such as receiving, put-away and order fulfillment. Acumax' Plus uses bar code technology, wrist-mounted computer hardware, and radio frequency signals to provide our customers with industry leading order quality and fulfillment at up to 99.9% accuracy. Closed Loop DistributionSM, which integrates portable Palm technology with Acumax' Plus to give customers complete ordering and inventory control, and Supply Management OnlineSM, an Internet-based ordering, purchasing, third-party reconciliation and account management system, help ensure that our customers have the right products at the right time for their facilities and patients.

Competition

In every area of healthcare distribution operations, our Pharmaceutical Solutions and Medical-Surgical Solutions segments face strong competition, both in price and service, from national, regional and local full-line, short-line and specialty wholesalers, service merchandisers, self-warehousing chains, and manufacturers engaged in direct distribution. In addition, these segments face competition from various other service providers and from pharmaceutical and other healthcare manufacturers (as well as other potential customers of the segments) which may from time to time decide to develop, for their own internal needs, supply management capabilities which are provided by the segments and other competing service providers. Price, quality of service, and, in some cases, convenience to the customer are generally the principal competitive elements in these segments.

Our Information Solutions segment experiences substantial competition from many firms, including other computer services firms, consulting firms, shared service vendors, certain hospitals and hospital groups, hardware vendors and Internet-based companies with technology applicable to the healthcare industry. Competition varies in size from small to large companies, in geographical coverage, and in scope and breadth of products and services offered.



   Company Address: 6555 State Hwy 161 Irving 75039 TX
   Company Phone Number: 446-4800   Stock Exchange / Ticker: NYSE MCK


Customers Net Income grew by MCK's Customers Net Profit Margin grew to

54.11 %

3.9 %

• Customers Performance • Customers Expend. • Customers Efficiency • List of Customers


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
CAH        0.97% 
COR   -0.05%    
CVS   -0.21%    
HLF   -12.64%    
BDX   -1.38%    
CI   -1.56%    
• View Complete Report
   



Business Update

McKesson Restructures for Strategic Growth Amidst Rising Costs and Supplier Pressures

Published Fri, Sep 19 2025 8:39 AM UTC

In a decisive move to streamline operations and bolster its competitive positioning, McKesson Corporation (NYSE: MCK) recently unveiled a new organizational structure, set to take effect in the second quarter of fiscal year 2026. This significant shift reflects McKesson s commitment to enhancing strategic alignment and improving transparency within its reportable segments, a...

Business Update

McKessons Strategic Acquisition A New Era in Ophthalmology and Financial Resilience

Published Wed, Apr 2 2025 3:10 PM UTC

In a significant move to bolster its position in the healthcare sector, McKesson Corporation has completed its acquisition of a controlling interest in PRISM Vision Holdings, LLC, a prominent provider of general ophthalmology and retina management services. This acquisition, valued at approximately $850 million, reflects McKesson s strategic intent to expand its footprint wi...

Business Update

Navigating Growth Waters How McKessons Strategic Realignment Is Rocketing Its Market Stature,

Published Sat, Jan 4 2025 6:21 PM UTC

McKesson s Strategic Shift: Divesting Some, Growing MoreOn December 30, 2024, McKesson Corporation, a leading name in healthcare services and information technology, finalized the sale of its Canadian subsidiaries, Rexall and Well.ca, to Birch Hill Equity Partners. This move, initially announced in September, signifies a strategic pivot for McKesson, allowing the company to...

Business Update

McKesson Corporation Streamlines Operations with Strategic Divestitures and Acquisitions in Oncology Sector

Published Sat, Jan 4 2025 4:15 PM UTC

In a significant move to sharpen its operational focus and capital allocation, McKesson Corporation (NYSE: MCK) has completed the divestiture of its Canada-based Rexall and Well.ca businesses to Birch Hill Equity Partners, a prominent Canadian private equity firm. Announced in September 2024 and finalized on December 30, 2024, this strategic transaction is a pivotal part of ...

Business Update

Prescription for Change McKessons Strategic Leap from Retail to Oncology,

Published Sat, Jan 4 2025 2:45 PM UTC

McKesson s Bold Pivot: From Rexall to Oncology Is It the Right PrescriptionIn a strategic move set to reshape its focus, McKesson Corporation has formally divested its Canada-based Rexall and Well.ca businesses, sealing the deal with Birch Hill Equity Partners on December 30, 2024. This transaction marks another chapter in McKesson’s ongoing evolution within the ever-compe...




Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) 23.11
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) 0.27
Price to Sales (Expected) -
Price to Book -
PEG (TTM) 0.47

Financial Strength Current
Quick Ratio 0.06
Working Capital Ratio 0.86
Leverage Ratio (MRQ) -
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) 0.66

Per Share Current
Earnings (TTM) 38.31 $
Revenues (TTM) 3250.85 $
Cash Flow (TTM) -
Cash 32.03 $
Book Value -
Dividend (TTM) 3.17 $

Efficiency Current
Revenue per Employee (TTM) 7,910,392
Net Income per Employee (TTM) 99,980
Receivable Turnover Ratio (TTM) 14.33
Inventory Turnover Ratio (TTM) 15.18
Asset Turnover Ratio (TTM) 4.92

Profitability Ratios Current
Gross Margin (MRQ) 4.2 %
Operating Margin (MRQ) 2.23 %
Net Margin (MRQ) 1.93 %
Net Cash Flow Margin (MRQ) 1.05 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) 6.22 %
Return On Investment (TTM) 50.92 %
Return On Equity (TTM) -
Dividend Yield 0.37 %
Pay out Ratio (TTM) 8.27 %



Mckesson's Segments
North American Pharmaceutical    83.2 % of total Revenue
Oncology Multispecialty    12.26 % of total Revenue
Prescription Technology Solutions    1.41 % of total Revenue
Medical-Surgical Solutions    2.82 % of total Revenue
Other    0.32 % of total Revenue

  Mckesson Outlook

On February 6 2025 the Mckesson provided following guidance

nnMcKesson Corporation Increases Fiscal 2025 Full-Year Adjusted EPS Guidance Following Third Quarter Resultsnn

On February 6, 2025, McKesson Corporation (NYSE: MCK), based in Irving, Texas, proudly announced its financial results for the third quarter of fiscal 2025. In a notable development, the company has elevated its projected full-year adjusted earnings per share (EPS) guidance for the fiscal year, reflecting its strong performance and optimistic outlook. However, specific figures or ranges for the revised adjusted EPS guidance were not disclosed in the announcement.

Investors looking for detailed financial metrics may access the third quarter results directly through McKesson's Invest...





Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.